Annovis Bio (ANVS)
NYSE:ANVS
Holding ANVS?
Track your performance easily

Annovis Bio (ANVS) Financial Statements

567 Followers

Annovis Bio Financial Overview

Annovis Bio's market cap is currently ―. The company's EPS TTM is $-3.85; its P/E ratio is -1.99; Annovis Bio is scheduled to report earnings on April 8, 2025, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -12.64M$ -5.02M$ -1.07M$ -14.86M$ -9.54M
EBITDA$ -12.64M$ -5.02M$ -1.07M$ -14.86M$ -9.54M
Net Income Common Stockholders$ -12.64M$ -5.02M$ -1.07M$ -14.72M$ -9.54M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 12.60M$ 4.00M$ 3.10M$ 6.35M$ 15.72M
Total Assets$ 14.36M$ 5.05M$ 7.81M$ 10.22M$ 22.82M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -12.60M$ -4.00M$ -3.10M$ -6.35M$ -15.72M
Total Liabilities$ 7.30M$ 6.80M$ 11.17M$ 3.56M$ 2.07M
Stockholders Equity$ 7.06M$ -1.75M$ -3.33M$ 6.66M$ 20.74M
Cash Flow-
Free Cash Flow$ -3.20M$ -3.38M$ -7.03M$ -9.37M$ -9.61M
Operating Cash Flow$ -3.20M$ -3.38M$ -7.03M$ -9.37M$ -9.61M
Investing Cash Flow-----
Financing Cash Flow$ 11.84M$ 4.24M$ 4.42M-$ 8.57M
Currency in USD

Annovis Bio Earnings and Revenue History

Annovis Bio Debt to Assets

Annovis Bio Cash Flow

Annovis Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis